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INTRODUCTION   
Diabetes Mellitus is a chronic metabolic disorder that 




The main complications of diabetes include 
abnormalities of the vessel wall structure and function, 
which results in both micro and macro vascular disease. 
Vascular disease is two to eight times more common in 
diabetic than non diabetic individuals, and remains the 
most important cause of death in diabetic patients
2
. The 
function of hyperglycemia has recently been studied as 
the most important factor in the beginning and 
progression of diabetic complications
3
. Although a 
number of factors are involved in the beginning of 
diabetic nephropathy, glomerular hyper filtration with 
increased intra glomerular pressure before dates the 
improvement of nephropathy and appears to put in to the 
diabetes linked renal injury 
4
. In 1988 approximately one 
third of these individuals will build up diabetic 
nephropathy
5
. About 30 to 40% of Diabetes Mellitus 
patients develop clear diabetic nephropathy which 
additionally impairs lipid metabolism
6
. 
In type 2 diabetes the course of diabetic nephropathy is 
less well differentiates, due to the often unknown date of 
beginning of disease or other causes influencing 
progression of nephropathy such as hypertension, age 
and other components of metabolic syndrome. Patients 
with diabetic nephropathy with type 2 diabetes have a 
high cardiovascular danger
7
. Thus in type 2 diabetes; 
numerous patients may not reach End Stage Renal 
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The research study was undertaken to investigate the effect of renal function impairment in insulin dependent and non insulin 
dependent diabetic patient in biochemistry department Hazara University Mansehra, Khyber pakhtunkhwa, Pakistan. For the 
study a District Head Quarter Hospital Bannu is selected. A total samples were taken from 100 individuals i.e. 33 insulin 
dependent, 33 non insulin dependent diabetic patients and 34 were control group. The blood samples from the individuals were 
collected for estimation of glucose in sodium flurried tube while urine, creatine and uric acid lithium heparin coated tube. 
Relevant data was recorded throughout the experiment till the termination of experiment; data was subjected to statistical 
analysis using ANOVA design. Level of significance (P<0.05) were taken in every group. In this experiment weight was found 
significant in both groups as compared to control, while other the population, habits, nutrition and body mass index (gender, 
age, ethnic groups, location, marital status, occupation income/month, smoking, alcohol, drugs, dietary habits, dietary 
assessment, obesity, height) were no significant(P<0.05) value observed in different groups of diabetic patients in all above 
parameters. In case of disease effects, body effects, serum, urinary profile the parameters (duration, family history of disease, 
treatment, blood sugar, blood urea, blood creatinine, urinary protein, urinary sugar) were found high significant (P<0.05) valve 
in both groups of diabetic patients, while the other parameters  (diabetes, diabetes types, allergy, blood pressure (Upper) blood 
pressure (Lower), radial pulse, hypertension, heart disease, doctor visit, and uric acid) were no significant (P>0.05) value 
between the different groups. It is concluded that renal function were affected in both groups of diabetic patients on the basis of 
receiving data from the above different parameters. 
Key words: insulin dependent, non-insulin dependent, diabetic patients, Control           
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The earliest clinical indication of nephropathy is the 
look of low but abnormal levels (>30 mg/day or 
20ug/min) of albumin in the urine, i.e. 
microalbuminuria  about 80% of type 1 diabetes who 
develop continued microalbuminuria have their urinary 
albumin excretion speed increase from 10-20% per 
year. Once nephropathy happens, the glomerular 
filtration rate (GFR) slowly falls over a period of 
several years at a rate that is highly changeable from 
individual to individual (2-20 ml/min/year)
9
. 
Recent studies pointed out that the majority diabetic 
complications like nephropathy are vascular initiated
10
. 
Diabetic nephropathy is the main reason of morbidity 
and mortality in diabetic patients and in adults constant 
“microalbuminuria” urinary albumin excretion rate is 




 The laboratory marker that has long served as the 
foundation for detecting impaired renal function is 
serum creatinine. The second factor is that the opposite 
relationship between GFR and serum creatinine expects 
that the large reductions in GFR from normal produce 
absolute increases in serum creatinine
12
.  Glomerular 
filtration rate (GFR) expects double chances 
progression to diabetic kidney disease
13
. 
MATERIALS AND METHODS  
Patients' selection 
Previously registered diabetic patients with type 1 and 
type 2 diabetes mellitus of both sexes admitted in 
diabetic wards and visiting outdoor patients of DHQ 
Hospital Bannu, women and children Hospital Bannu, 
were selected for the study after informed consent was 
obtained. The age of patients was more than 20 years. 
Their diabetes age was more than one year. The study 
procedure was approved by the regulations of Medical 
superintendent (MS) of DHQ Hospital Bannu, for the 
use of human subjects in research. 
Exclusive criteria  
The following patients were excluded from the study: 
 Individuals with urinary tract infection 
 Pregnant diabetic women 
 Patients having any mental disorder 
 Individuals having any past medical history of 
various vascular complications before the diagnosis 
of diabetes mellitus such as heart failure or renal 
failure. 
 Those who did not consent to participate in the 
study.  
Study design 
Total one hundred (100) individuals were selected as 
sample of the study. Out of these 33 individuals were 
insulin dependent diabetic patients, 33 non insulin 
dependant diabetic patients while 34 individuals were 
taken as a control group. 
Sampling technique  
Convenient/non probability sampling.  
Development of questionnaire 
Questionnaire was used as a tool for collection of data. 
The questionnaire consists of 36 items. Same 
questionnaires were used for all the three groups. 
Questionnaire were used to note all about blood 
parameters like blood sugar, blood urea, blood 
creatinine, blood uric acid, urinary protein, and urinary 
sugar including demographic features of all the diabetic 
patients and control group.  
Sample collection  
The fasting blood samples were collected from each 
patient and control after 12-hour of fasting. It was 
ensured that the patient has not taken any anti diabetic, 
anti hypertensive drug known to influence the glycemic 
status and renal function. The blood samples for 
estimation of glucose were collected in sodium fluoride 
tube while urea, creatinine and uric acid in lithium-
heparin coated tubes.  
Sample preparation  
Serum was separated from the clotted blood through 
centrifuge to analyze blood parameters. Blood samples 
were processed the same day for estimations of sugar, 
urea, creatinine, uric acid. 
Analysis 
(A)    Quantitative analysis 
(i )      Estimation of blood glucose by ezymatic 
alorimetric  method. 
Procedure     
2 ml Glucose solution was taken in a tube. Then added 
0.2ml of clear serum. In another tube 2 ml glucose 
reagent and 0.2 ml standard was taken. Then mixed it, 
placed in water bath at 37
0
 C for 10 minutes. Then 
absorbance was taken through colorimeter. But before 
the examination, the machine was adjusted at 0 levels 
with distilled water. Concentration of glucose in 
serum was calculated in terms of mg/dl.  
 Results were calculated by using the following formula   
T (Sample) 
C = 100 x  --------------------  (mg / dl) 
S (Standard) 
(ii) Estimation of blood urea by ezymatic 
calorimetric method. 
Procedure     
2 ml Urea solution was taken in a tube. Then added 
0.2ml of clear serum. In another tube 2 ml urea reagent 
and 0.2 ml standard was taken. Then mixed it, placed in 
water bath for 37
0
 C and waited for 10 minutes. Then 
absorbance was taken through colorimeter. But before 
examination machine was adjusted at 0 levels with 
distilled water. 
 Results were calculated by using the following 
formula: 
      T (Sample) 
C = 50 x   ------------------   (mg / dl) 
S (Standard) 
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(iii) Estimation of uric acid by ezymatic 
calorimetric method. 
Procedure  
2 ml Uric Acid solution was taken in a tube. 
Then added 0.2ml of clear serum. In another tube 2 ml 
uric acid reagent and 0.2 ml standard was taken. Then 
mixed it and waited for 10 minutes, placed in water bath 
for 37
0
 C. Then absorbance was taken through 
colorimeter. 
 Results were calculated by using the following formula      
T (Sample) 
C = 8 x   ----------------   (mg / dl) 
S (Standard) 
(iv)  Estimation of blood creatinine by 
ezymatic calorimetric method . 
Procedure     
2 ml Creatinine solution was taken in a tube .Then 
added 0.2ml of clear serum. In another tube 2 ml 
creatinine reagent and 0.2 ml standard was taken. Then 
mixed it and waited for 10 minutes, placed in water bath 
for 37
0
 C. Then absorbance was taken through 
colorimeter. 
Results were calculated by using the following formula:   
T (Sample) 
C = 2 x  -------------------  (mg / dl) 
S (Standard) 
(B) Qualitative analysis  
( i ) Determination of urinary glucose by benedicts 
method    
Procedure 
5ml Benedict solution in clean test tube was taken.  
Then heated  the solution till boiling for two minutes. 
Then putted 8 drops of fresh urine and boiling up to 2 
minutes.  
Report  
The glucose concentration was as follows: 
 
 
Appearance of the solution 
COLOUR                        GRADATION            PERCENTAGE. 
- Blue                                        (--) Nil                     0 % 
Green Non precipitation           (+)                         trace less than 
=   =     =    =    =                       (+)                                 0.25 mg/dl 
Yellow & cloudy                  (+ +)                           0. 5 % 
Orange & cloudy                      (+ + +)                               1 % 
Dark & cloudy                          (+ + + +)                             1. 5 
 
 
(ii) Determination of urinary protine by 
heat method. 
3/4 ml urine was taken in a tube. Heated it while 
rotating the tube urine if become clouded protein 
or Phosphates were presents. Then added 2-3 drops 
of acetic acid, if turbidity persists, then protein 
was present in urine.  
 
Report  
The urinary protein concentration was obtained as 
follows. 
GRADATION                        PERCENTAGE 
Trace                20mg 
+                30mg 
 ++     50mg 




Table 1 describes that no significant (p>0.05) value was 
observed in both type ID/NID diabetic patients, as 
compared to control group. The parameters like gender, 
age, ethnic groups, location, marital status and 
occupation in diabetic patients were no significant 
(p>0.05) value observed. While in case of 
income/month of the population significant (p>0.05) 
value were observed. 
Table 2 shows no significant (p>0.05) value in both 
type ID/NID diabetic patients as compared to control 
group. All parameters like smoking, alcohol, drugs, 
dietary habits, and dietary assessment  In Table 2 
were no significant (p>0.05) value  
Table 3 shows no significant (p<0.05) value in 
parameters like obesity, height in both (ID/NID) types 
of diabetic patients as compared to control. While in 
case of weight significant (p<0.05) value was observed 
in both types diabetic patients. Which prove that weight 
effect renal function impairment in insulin dependent 
and non-insulin dependent diabetic patients.  
Table 4 indicates high significant (p<0.05) value in 
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various parameters in  both types (ID/NID) of diabetic 
patients  like duration of diabetes, family history and 
treatment as compared to control groups.While for 
parameter of allergy no significant (p>0.05)value was 
obtained .  
The parameters in both types of diabetic patients were 
given in Table 5. The results show no significant  
(p<0.05) value in parameters like BP upper, BP lower, 
radial pulse, hypertension, heart disease and doctor visit 
in both types of diabetic patients as comparison to 
control group. 
Table 6 shows significant (p<0.05) value in various 
blood parameters in both types’ diabetic patients. The 
blood parameters like blood cretinine and uric acid no 
significant (p<0.05) value were observed as compared 
to control group. While parameter like blood sugar, 
blood urea, urinary sugar, urinary protein were high 
significant (p<0.05) value in diabetic patients .which 
indicate the risk of renal function impairment in insulin 
and non insulin dependent diabetic patients is greater as 
the compare to control group.  
 
 
Table 1 Comparison of insulin dependent and non insulin dependent (ID/NID) groups of diabetic patients  
in various parameters with Control in the Study of population, (Gender, Age, Ethnic group , Location, 
Marital status, Occupation, Income/month).  
 n=100 
 p<0.05 as compared to control group. 
 BG: Between Groups. 
 WG: Within Groups 
 
Table 2 Comparison of insulin dependent and non insulin dependent (ID/NID) groups of diabetic patients  
in various parameters with control in the Study of habits and nutrition’s (Smoking, Alcohol, Drugs, 
Dietary Habits, Dietary Assessment).  
 n=100 
 p<0.05 as compared to control subjects. 
 BG: Between Groups. 
 WG: Within Groups. 
 
 
S/No Parameter Groups –
Interaction 
Sum Sum of 
Sq 
Df Mean Std. D F P –value 
1 Gender BG/WG 130 21.000 99 1.30 .461 .384 .682 
2 Age BG/WG 149.00 38.990 99 1.4900 .62757 2.585 .081 
3 Ethnic 
Groups 
BG/WG 212.00 150.560 99 2.1200 1.23321 .537 .586 
4 Location BG/WG 255 98.750 99 2.55 .999 .557 .575 
5 Marital 
Status 
BG/WG 114 12.040 99 1.14 .349 3.527 .033 
6 Occupation BG/WG 
Total 
319 245.390 99 3.19 1.574 1.522 .224 
7 Income BG/WG 344.00 226.640 99 3.4400 1.51304 5.608 .005 
S/No Variable Groups -
Interaction 
Sum Sum of 
Squares 
df Mean Std. 
Deviation 
F P-value 
1 Smoking BG/WG 
Total 
155.00 24.750 99 1.5500 .50000 1.101 .337 
2 Alcohols BG/WG 
Total 
200.00 .000 99 2.0000 .00000 1.706 .108 
3 Drugs BG/WG 
Total 
179.00 16.590 99 1.7900 .40936 2.378 .098 









144.00 24.640 99 1.4400 .49889 2.467 .090 
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Table 3: Comparison of insulin dependent and non insulin dependent (ID/NID) groups of diabetic patients  
in various parameters with Control in the Study of BMI (Obesity, Height, Weight) 
S/No Parameter Groups -
Interaction 
Sum Sum of 
Squares 




1 Obesity BG/WG 164.00 23.040 99 1.6400 .48242 1.884 .157 
2 Height BG/WG 165.00 22.750 99 1.6500 .47937 .456 .635 
3 Weight BG/WG 284.00 43.440 99 2.8400 .66241 8.663 .000 
 n=100 
 p<0.05 as compared to control subjects. 
 BG: Between Groups. 
 WG: Within Groups. 
 
Table 4: Comparison of insulin dependent and non insulin dependent (ID/NID) groups of diabetic 
patients in various parameters with control in the Study of disease effects, (Diabetes, Duration, 
Diabetes Type, Family History, Treatment and Allergy). 
S/No Parameter Groups 
Interaction 
Sum Sum of 
Squares 
df Mean Std. 
Deviation 
F P-value 
1 Diabetes BG/WG 
Total 
134.00 22.440 99 1.3400 .47610 20.342 .054 
2 Duration BG/WG 
Total 
222.00 125.160 99 2.2200 1.12439 79.254 .000 
4 Diabetes Type BG/WG 
Total 





145.00 24.750 99 1.4500 .50000 19.908 .000 






1.4100 .49431 143.164 .000 
7 Allergy BG/WG 
Total 
178.00 17.160 99 1.7800 .41633 .034 .967 
 n=100 
 p<0.05 as compared to control subjects. 
 BG: Between Groups. 
 WG: Within Groups. 
 
Table 5: Comparison of (ID/NID) groups of diabetic patients  in various parameters with control in 
the Study of body effects (BP Upper, BP Lower, Radial Pulse, Hypertension, Heart Disease & Doctor 
Visit) body effects. 
S/No Parameter Groups –
Interaction 




1 BP Upper BG/WG 
Total 
217.00 64.110 99 2.1700 .80472 1.128 .328 
2 BP Lower BG/WG 
Total 
136.00 41.040 99 1.3600 .64385 3.033 .053 
3 Radial Pulse BG/WG 
Total 
183.00 14.110 99 1.8300 .37753 5.952 .004 




24.840 99 1.5400 .50091 1.384 .255 




175.00 18.750 99 1.7500 .43519 .772 .465 
6 Doctor  Visit BG/WG 
Total 
147.00 24.910 99 1.4700 .50161 5.263 .007 
 n=100 
 p<0.05 as compared to control subjects. 
 BG: Between Groups. 
 WG: Within Groups. 
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Table 6: Comparison of (ID/NID) groups of diabetic patients in various parameters with control in 
the Study of serum/urinary profile, (Blood Sugar, Blood Urea, Blood Cretinine, Urinary Sugar, 
Urinary Protein, and Uric Acid).  
 n=100 
 p<0.05 as compared to control subjects. 
 BG: Between Groups. 
 WG: Within Groups 
 
DISCUSSION  
Diabetes mellitus has become the mainly common 
single cause of renal function impairment in various 
parts of the world in general, and in rising countries in 
particular. Diabetes mellitus and hypertension are 
interconnected diseases
14
. Diabetes causes unique 
changes in kidney structure
15
. In present study, we 
evaluated the variation in normal renal functions. The 
development of diabetic complications is varies 
amongst different ethnic groups
16
. The development of 
chronic complications of diabetes are known to be 
interconnected to certain factors such as increased age, 
gender and occupation
17
.In the present study there were 
no significant (P>0.05) value observed in different 
parameters like ethnic groups, age, gender and 
occupation shown in Table 1.The result shows a 
contrast relation to the previous study of (USRDS, 
2003, Nicolucci at al,1998)
16,17
 about diabetes patients. 
However there were no previous relevant studies 
conducted about the parameters like location, 
income/month and marital status. 
The Studies of the development of complications in 
diabetes is in longer period of smoking, history of drugs 
and alcohol
18
, less dietary assessment in diabetes has 
shown diabetic nephropathy
19
, also to be the leading 
cause to End Stage Renal Disease (ESRD)  has been 
seen effected by smoking, history of drugs and 
alcohol
20
. It is documented in a variety of previous 
studies that the above parameters significantly affect on 
diabetes patients. In our study no significant (p>0.05) 
value was observed (Table 2). The results of present 
study given in Table (2) were not in the line with the 
previous studies of (MRFITR, 1993, Wannamettee at 
al, 2000, Shera et al, 2004)
18-20
.  
Increased body weight is widely accepted as the clinical 
sign of diabetic nephropathy patients
21
. Overall obesity 
and high abdominal fats “central obesity” are 
particularly more prevalent in individuals with Type 2 
diabetes. Central obesity and diabetes association is 
particularly greater in women and the taller individuals 
are more probable to develop diabetic nephropathy than 
shorter ones
22
, (Dawn, 2001). It is observed in our study 
that in case of parameters like obesity and height no 
significant (p>0.05) value is observed in table (3) which 





. while increased body weight, significant 
(p<0.05) value found as compared to low weight 
diabetic patient (Table 3).These results of our study 
indicate similarity to previous study reported of 
(Caramori et al, 2003)
21
.  
 A family history, no enough treatment and longer 
duration of diabetes have  a  major risk factors for 
diabetes in  worldwide. In Pakistan about 44 percent of 
people with Type 2 diabetes patients have a positive 
family history of diabetes
23
. The present study show 
high significant (p<0.05) value which is visible in the 
case of parameters like family history, longer duration 
of diabetes and no enough treatment. In our study, high 
significant effect in the above parameters of diabetes 
were shows same case like the previous study of 
(Hashim et al, 1999)
23
. While no previous relevant 
study was found about the parameter of allergy in 
(Table 4).  
Although microalbuminuria is usually the first symptom 
of diabetic renal disease
24
. In patient blood pressure and 
hypertension may proceed before time its development. 
Hypertension is also a major risk factor for 
cardiovascular events, such as stroke as well as micro 
vascular complications such as retinopathy and 
nephropathy
25
. But our study (Table 5) not shows 
significant effects of blood pressure and hypertension 
on renal function impairment in diabetic patients. Our 
findings were contrast to the result reported by other 
authors of (Lurbe et al, 2002, Carlos et al, 2002)
24,25
.  
It is also clear in our study that no strong and significant 
correlation were observed of diabetic patients and 
S/No Parameter Groups –
Interaction 
Sum Sum of 
Squares 
df Mean Std. 
Deviation 
F p-value 
1 Blood Sugar BG/WG 
Total 
209.00 168.190 99 2.0900 1.30341 104.917 .000 
2 Urinary Protein BG/WG 
Total 
179.00 16.590 99 1.7900 .40936 8.236 .000 
3 Urinary Sugar BG/WG 
Total 
176.00 18.240 99 1.7600 .42923 11.568 .000 
4 Blood Urea BG/WG 
Total 
165.00 56.750 99 1.6500 .75712 12.415 .000 
5 Blood Creatinine BG/WG 
Total 
138.00 43.560 99 1.3800 .66332 6.376 .003 
6 Blood Uric Acid BG/WG 
Total 
305.00 80.750 99 3.0500 .90314 1.123 .330 
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control with blood pressure and hypertension and also 
no significant correlations were observed between 
blood pressure and hypertension in diabetic patient 
about renal disease. These observations indicate the 
disturbances of individual body due to diabetes 
resulting only in increase hypertension as well as blood 
pressure.  
 Increased urea is widely accepted as the first clinical 
sign of renal function impairment. This indicates that 
serum urea is the first factor to indicate the weakening 
in kidneys of diabetic patients. It is also reported that 
the laboratory marker has long causes for the basis of 
detecting impaired kidney function is the serum 
creatinine
12
. A strong correlation was also observed 
between serum urea and creatinine in diabetic patients. 
It is therefore confirmed that higher the concentration of 
urea, more rapid will be the decline in the creatinine and 
the higher risk of weakening of renal function
26
. The 
present study in (Table 6) the parameter of serum urea 
levels were found significant (p<0.05) value in diabetes 
patients. It indicates that serum urea alone was a 
significant marker to evaluate the renal damage in 
diabetic kidney patients. In the present study blood 
creatinine also shows high significant (p<0.05) value. 
These show parallel end result to previous study of (Star 
et al, 2002, Adrogue et al,  1986)
12,26
.  
In patients with nephropathy the ratio of urinary protein 
and creatinine in a single specimen are interconnected. 
The patients with urinary protein and creatinine ratio 
more than normal had a progressive decrease in the 
kidney function. These also exceed 30 percent per year 
in urinary protein excretion patient more than four times 
than normal
27
. Present study (Table 6) shows high 
significant (p<0.05) value observed in case of 
parameters like protein and creatine. These prove a 




On the other hand, Microalbuminuria is a recognized 
risk factor for the development of diabetic nephropathy. 
Microalbuminuria may be observed as an early 
indicator of diabetic kidney disease, as renal structural 
abrasion can be detected at this stage. Patients with 
reduced renal functional reserve capacity may be more 
lying face down to microalbuminuria when exposed to 
conditions such as hyperglycemia. Hyperglycemia is 
related an independent risk for the loss of sugar in urine 
from diabetic patients
28
.The present study (Table 6) 
shows significant (p<0.05) value in parameters of blood 
sugar and urinary sugar in diabetic patients as compared 
to control (figure4.6). Which is valid resemblance to the 
previous study of (Lee, 2005)
28
. The result from present 
study in both types of diabetes patients indicate that an 
increased blood sugar level even within the normal 
range most likely reflects abnormal kidney function and 




The data of present study  about diabetes mellitus 
type1( ID ) and diabetes mellitus type 2 (NID) shows 
that an increased urea level even within the normal 
range in blood most likely to reproduce abnormal 
creatinine, which may proceed to diabetic renal function 
impairment in both types, insulin dependant and non 
insulin dependent diabetic patients.  
CONCLUSION  
In the last few years, we have faced vast care in the 
understanding of the risk factors and mechanisms of 
diabetic nephropathy, the stages of renal participation in 
diabetes, and the treatment plan to prevent or interrupt 
the development of diabetic nephropathy. 
From the findings of our present study, it is definitely 
indicated that the renal function are significantly 
changed during the development of diabetes mellitus 
disease. This also affects the abnormality in intra and 
extra cellular distributions of other complications. 
Increase blood urea and creatinine once developed 
precede the renal function impairment in insulin 
dependant and non insulin dependant diabetes patients. 
Hypertension in diabetes may precede the patients 
towards kidney weakening with all of its symptoms. 
Moreover the blood pressure control has been a 
challenge for health care professionals in checking their 
patients towards diabetic vascular complications. It is 
recommended that hard line antihypertensive treatment, 
and the use of Angiotensin Converting Enzyme 
(ACE) inhibitors or Angiotensin Receptor Blockers 
(ARB) treatment plan will slow the progression of 
diabetic nephropathy. Hyperglycemia is an independent 
risk factor for diabetic vascular complications. It is 
associated with loss of renal functions. Rigid glycemic 
control is a major objective in preventing the 
complications of diabetes for example the renal function 
and nephropathy. 
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